Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets

被引:8
|
作者
Belew, Sileshi [1 ,2 ,3 ]
Suleman, Sultan [1 ,2 ]
Duguma, Markos [1 ,2 ]
Teshome, Henok [1 ,2 ]
Wynendaele, Evelien [3 ]
Duchateau, Luc [4 ]
De Spiegeleer, Bart [3 ]
机构
[1] Jimma Univ, Lab Drug Qual JuLaDQ, POB 378, Jimma, Ethiopia
[2] Jimma Univ, Sch Pharm, POB 378, Jimma, Ethiopia
[3] Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, Ottergemsesteenweg 460, B-9000 Ghent, Belgium
[4] Univ Ghent, Fac Vet Med, Biometr Res Grp, Salisburylaan 133, B-9820 Merelbeke, Belgium
关键词
Artemether; Dissolution; In-vitro; Lumefantrine; PHYSICOCHEMICAL PROPERTIES; FALCIPARUM-MALARIA; CLASSIFICATION; SOLUBILITY; SURFACTANT; PROFILES; DRUGS;
D O I
10.1186/s12936-020-03209-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Dissolution of artemether (ART) and lumefantrine (LUM) active pharmaceutical ingredients (APIs) in fixed dose combination (FDC) ART/LUM tablets is one of the critical quality attributes. Thus, the verification of the release profile of ART and LUM from FDC ART/LUM tablets using a robust and discriminatory dissolution method is crucial. Therefore, the aim of this study was to develop and validate an appropriate dissolution method for quality control of FDC ART/LUM tablets. Methods The dissolution medium was selected based on saturation solubility data and sink conditions. The effect of agitation speed, pH and surfactant concentration on the release of ART and LUM was evaluated by employing a two-level factorial experiment. The resulting final method was validated for linearity, precision, robustness and API stability. In addition, the discriminatory power of the method was evaluated using expired and unexpired FDC ART/LUM products. Results A suitable dissolution profile of FDC ART/LUM tablets was obtained in 900 ml HCl (0.025 N, pH 1.6) with 1%Myrj 52 using paddle method at 100 rpm and 37 degrees C. ART and LUM were analysed using a HPLC method with UV detection at wavelengths of 210 and 335 nm, respectively. The results from the stability study showed that ART and LUM were sufficiently stable in HCl (0.025 N, pH 1.6) with 1%Myrj 52 at 37 degrees C. The method was linear (r(2) = 0.999) over the concentration range of 6.25-100 mu g/ml. The results for precision were within the acceptance limit (%RSD < 2). The percent relative standard deviation (< 2%) and statistically non-significant (p > 0.05) difference in release of ART and LUM observed between deliberately changed dissolution method settings (pH = 1.6 +/- 0.2 or agitation speed = 100 +/- 2) and optimized dissolution conditions revealed the robustness of the dissolution method. The method was capable to discriminate among different FDC ART/LUM products with different quality. Conclusions The developed dissolution method is robust and discriminatory. It can be used in the quality evaluation of FDC ART/LUM tablets.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
    Ali, Shabana
    Najmi, Muzammil H.
    Tarning, Joel
    Lindegardh, Niklas
    MALARIA JOURNAL, 2010, 9
  • [32] Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
    Shabana Ali
    Muzammil H Najmi
    Joel Tarning
    Niklas Lindegardh
    Malaria Journal, 9
  • [33] Formulation, process development and evaluation of artemether and lumefantrine soft gelatin capsule
    Patel, A.
    Lodha, A.
    Chaudhuri, J.
    Jadia, P.
    Joshi, T.
    Dalal, J.
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2012, 4 (05): : S98 - S100
  • [34] FTIR SPECTROPHOTOMETRIC METHOD FOR THE SIMULTANEOUS ESTIMATION OF ARTEMETHER AND LUMEFANTRINE IN BULK AND FORMULATIONS
    Prasanth, S. S.
    Rukku, Snij A.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2019, 10 (06): : 2975 - 2980
  • [35] Costs, effects and cost effectiveness of artemether lumefantrine in zambia
    Masiye, Felix
    Chanda, Pascalina
    Moonga, Hawela
    Banda, Patrick
    Chitah, Bona
    Sipilanyambe, Naawa
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05): : 153 - 153
  • [36] Investigating In Vitro and Ex Vivo Properties of Artemether/Lumefantrine Double-Fixed Dose Combination Lipid Matrix Tablets Prepared by Hot Fusion
    Wilkins, Christi A.
    du Plessis, Lissinda H.
    Viljoen, Joe M.
    PHARMACEUTICS, 2021, 13 (07)
  • [37] Coartem (Artemether-Lumefantrine) in Africa: The beginning of the end?
    Hastings, IM
    Ward, SA
    JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (07): : 1303 - 1304
  • [39] Suspected allergy to artemether-lumefantrine treatment of malaria
    Krippner, R
    Staples, J
    JOURNAL OF TRAVEL MEDICINE, 2003, 10 (05) : 303 - 305
  • [40] New drugs: Golimumab, besifloxacin hydrochloride, and artemether/lumefantrine
    Hussar, Daniel A.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2009, 49 (04) : 570 - +